Active substance
Results for the substance indacaterol glycopyrronium bromide mometasone
2 results
About this active substance
The combination of indacaterol, glycopyrronium bromide, and mometasone is used for the treatment of chronic obstructive pulmonary disease (COPD) and severe asthma. Indacaterol is a long-acting beta-2 adrenergic agonist, glycopyrronium is an anticholinergic, and mometasone is a corticosteroid that reduces inflammation.
The medication is administered via inhalation, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include cough, dry mouth, headache, or throat irritation. In rare cases, severe allergic reactions or paradoxical bronchospasm may occur.
This combination is not recommended for patients with hypersensitivity to any of the components or severe cardiac conditions.
The medication is administered via inhalation, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include cough, dry mouth, headache, or throat irritation. In rare cases, severe allergic reactions or paradoxical bronchospasm may occur.
This combination is not recommended for patients with hypersensitivity to any of the components or severe cardiac conditions.